𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Microsatellite alterations and p53, TGFβRII, IGFIIR and BAX mutations in sporadic non-small-cell lung cancer

✍ Scribed by Maria A. Caligo; Chiara Ghimenti; Antonio Marchetti; Antonino Lonobile; Fiamma Buttitta; Silvia Pellegrini; Generoso Bevilacqua


Publisher
John Wiley and Sons
Year
1998
Tongue
French
Weight
76 KB
Volume
78
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Fifty-two sporadic primary non-small-cell lung carcinomas (NSCLC) were examined for microsatellite instability. Six different microsatellite markers localized on chromosomes 2, 5, 8, 10, 11 and 17 were used. Genomic instability was observed in 35% (18/52) of NSCLC at single or multiple loci. The tumors were also analyzed for p53-gene mutations by PCR-SSCP analysis. Polynucleotide stretch frameshift mutations of TGF␤RII (transforming-growth-factor-beta receptor II), IGFIIR (insuline growth-factor II receptor) and BAX genes were also analyzed. RER ؉ (replication-error-positive) tumors appear not to be affected by a higher rate of point mutations in coding sequences: no correlation was found between microsatellite instability and point mutations in the p53 gene, and the RER ؉ tumors showed no alterations in stretches of nucleotide inside TGF␤RII,


📜 SIMILAR VOLUMES


Survival in operable non-small-cell lung
✍ Thanos Sioris; Kirsti Husgafvel-Pursiainen; Antti Karjalainen; Sisko Anttila; An 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 68 KB 👁 2 views

Validated markers are needed to identify operable lung cancer patients with poor prognosis. About one-half of nonsmall-cell lung cancers (NSCLCs) carry a mutation in the p53 tumor-suppressor gene. We examined 101 NSCLC patients for surgical stage, completeness of resection, tobacco smoking, asbestos